Literally millions of Americans use proton pump inhibitors—whether by prescription or OTC—and some have done so for an extended period of time. Find out why a new study suggests that might be ill-advised and how pharmacists might counsel patients.

Weight-Loss Medications Underused Despite
Guideline Recommendations

With the high rate of obesity in the United States and the availability of FDA-approved therapies, new research finds it surprising that pharmacists aren’t filling more prescriptions for weight-loss medications. Learn which products were most often prescribed and how closely patients adhered to those regimens.

Androgen-Deprivation Users Need to Understand Mental Health Risks

Androgen-deprivation therapy (ADT) might have value in limiting progression in patients with localized prostate cancer, but the benefit apparently comes at a cost. A new study finds that ADT significantly increases the risk of depression in men who use it. Here is more information on how pharmacists should caution patients.